(Q46613928)

23 December 2017

title

In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations (English)

1 reference

23 December 2017

author

Thomas Rades

5

1 reference

23 December 2017

author name string

Regina Scherließ

1

1 reference

23 December 2017

Simon Buske

2

1 reference

23 December 2017

Katherine Young

3

1 reference

23 December 2017

Benjamin Weber

4

1 reference

23 December 2017

Sarah Hook

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

9 August 2013

1 reference

23 December 2017

published in

Vaccine

1 reference

23 December 2017

volume

31

1 reference

23 December 2017

issue

42

1 reference

23 December 2017

page(s)

4812-4819

1 reference

23 December 2017

The rational design of vaccines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Delivery of antigens used for vaccination: recent advances and challenges.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Recent advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Immunostimulatory colloidal delivery systems for cancer vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Delivery strategies to enhance mucosal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Vaccine adjuvants: current challenges and future approaches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitosan for mucosal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitosan as a novel nasal delivery system for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Clearance characteristics of chitosan based formulations in the sheep nasal cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Absorption Enhancers for Nasal Drug Delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitosan and its derivatives in mucosal drug and vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitin is a size-dependent regulator of macrophage TNF and IL-10 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Immunogenicity of protein therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Immunogenicity of protein aggregates--concerns and realities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

A validated 1H NMR method for the determination of the degree of deacetylation of chitosan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

T cell receptor antagonist peptides induce positive selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Adoptive transfer of transgenic T cells to study mucosal adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

In vivo activity of cationic immune stimulating complexes (PLUSCOMs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Particulate vaccines: on the quest for optimal delivery and immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Nanoparticles for nasal vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Adjuvant activity of chitin derivatives in mice and guinea-pigs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Stimulation of cytokine production in mice using deacetylated chitin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

The effect of particle design on cellular internalization pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

Chitosan-based delivery systems for protein therapeutics and antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.081

10.1016/J.VACCINE.2013.07.081

7 January 2021

Identifiers

DOI

1 reference

23 December 2017

release_uvfn6ny24fhkbdfgwsqnzjhj5q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uvfn6ny24fhkbdfgwsqnzjhj5q

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23933339

1 reference

23 December 2017